Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Feb;88(1):1-13.
doi: 10.1139/o09-121.

Applying Hsp104 to protein-misfolding disorders

Shilpa Vashist  1 , Mimi Cushman, James Shorter
Affiliations
Review

Applying Hsp104 to protein-misfolding disorders

Shilpa Vashist et al. Biochem Cell Biol. 2010 Feb.

Abstract

Hsp104, a hexameric AAA+ ATPase found in yeast, transduces energy from cycles of ATP binding and hydrolysis to resolve disordered protein aggregates and cross-beta amyloid conformers. These disaggregation activities are often co-ordinated by the Hsp70 chaperone system and confer considerable selective advantages. First, renaturation of aggregated conformers by Hsp104 is critical for yeast survival after various environmental stresses. Second, amyloid remodeling by Hsp104 enables yeast to exploit multifarious prions as a reservoir of beneficial and heritable phenotypic variation. Curiously, although highly conserved in plants, fungi and bacteria, Hsp104 orthologues are absent from metazoa. Indeed, metazoan proteostasis seems devoid of a system that couples protein disaggregation to renaturation. Here, we review recent endeavors to enhance metazoan proteostasis by applying Hsp104 to the specific protein-misfolding events that underpin two deadly neurodegenerative amyloidoses. Hsp104 potently inhibits Abeta42 amyloidogenesis, which is connected with Alzheimer's disease, but appears unable to disaggregate preformed Abeta42 fibers. By contrast, Hsp104 inhibits and reverses the formation of alpha-synuclein oligomers and fibers, which are connected to Parkinson's disease. Importantly, Hsp104 antagonizes the degeneration of dopaminergic neurons induced by alpha-synuclein misfolding in the rat substantia nigra. These studies raise hopes for developing Hsp104 as a therapeutic agent.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Protein disaggregation by Hsp104. Hsp104 couples energy from ATP binding and hydrolysis to dissolve denatured protein aggregates and amyloid fibers. Hsp70 and Hsp40 co-ordinate the disaggregation of denatured protein aggregates, whereas they are less essential for the dissolution of amyloid structure. Note the 3-tiered structure of Hsp104, and the substrate-binding Tyr motifs that project into the central channel (denoted by small Y-shapes).
Fig. 2
Fig. 2
Co-ordination of Hsp104 ATPase activity is required for protein disaggregation. (a) In the presence of ATP, Hsp104 engages denatured aggregates too transiently to initiate disaggregation. (b) In the presence of specific mixtures of ATP and ATPγS (e.g., 3 ATP : 1 ATPγS), Hsp104 is able to productively couple substrate binding to translocation and disaggregation. Only specific ratios of ATP and ATPγS are effective, and pure ATPγS inhibits activity (Doyle et al. 2007b). (c) In the presence of ATP, specific Hsp104 mutants with reduced ATPase activity at NBD2, such as N728A or K620T, can productively couple substrate binding to translocation and disaggregation (Doyle et al. 2007b). Despite this innate ability to disaggregate some disordered aggregates, these mutants fail to disaggregate amyloid and are unable to synergize with the Hsp70 chaperone system and are defective in vivo (Doyle et al. 2007b; Hattendorf and Lindquist 2002; Shorter and Lindquist 2004). (d) In the presence of ATP, Hsp70 and Hsp40 ensure productive substrate binding by Hsp104, which leads to translocation and disaggregation. (e) In the presence of ATP, Hsp104 is able to bind and disaggregate amyloid substrates.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Alberti S, Halfmann R, King O, Kapila A, Lindquist S. A systematic survey identifies prions and illuminates sequence features of prionogenic proteins. Cell. 2009;137(1):146–158. doi:10.1016/j.cell.2009.02.044. PMID:19345193. - PMC - PubMed
    1. Anfinsen CB. Principles that govern the folding of protein chains. Science. 1973;181(96):223–230. doi:10.1126/science.181.4096.223. PMID:4124164. - PubMed
    1. Arimon M, Grimminger V, Sanz F, Lashuel HA. Hsp104 targets multiple intermediates on the amyloid pathway and suppresses the seeding capacity of Abeta fibrils and protofibrils. J. Mol. Biol. 2008;384(5):1157–1173. doi:10.1016/j.jmb.2008.09.063. PMID:18851977. - PubMed
    1. Arrasate M, Mitra S, Schweitzer ES, Segal MR, Finkbeiner S. Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature. 2004;431(7010):805–810. doi:10.1038/nature02998. PMID:15483602. - PubMed
    1. Bainbridge JW, Smith AJ, Barker SS, Robbie S, Henderson R, Balaggan K, et al. Effect of gene therapy on visual function in Leber's congenital amaurosis. N. Engl. J. Med. 2008;358(21):2231–2239. doi:10.1056/NEJMoa0802268. PMID:18441371. - PubMed

Publication types

LinkOut - more resources